Agomelatine for the treatment of generalised anxiety disorder

Description

In this Product Explainer, Psychiatrist Prof Sean Hood explains the role of the antidepressant agomelatine in the treatment of Generalised Anxiety Disorder (GAD) (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Dennis Lau

Prof Dennis Lau

Postural Orthostatic Tachycardia Syndrome – What You Need to Know

Prof Tony Attwood

Prof Tony Attwood

Autism Assessment in the GP Setting

Prof Brendon Yee, A/Prof Ralph Audehm

Prof Brendon Yee, A/Prof Ralph Audehm

Obstructive Sleep Apnoea – Practical Updates

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Asthma Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sean Hood

expert

Prof Sean Hood

Psychiatrist; Head, University of Western Australia, Division of Psychiatry in the Medical School; Associate Dean, Faculty of Health and Medical Sciences

Date published: 8 August 2022